US9770570 — Apparatus and method for monitoring nitric oxide delivery
Method of Use · Assigned to Mallinckrodt Hospital Products IP Unlimited Co · Expires 2036-05-03 · 10y remaining
What this patent protects
This patent protects an apparatus and method for monitoring nitric oxide delivery, particularly when the flow of breathing gas deviates from a predetermined level or range.
USPTO Abstract
Described is an apparatus for monitoring nitric oxide delivery, wherein such apparatus comprises an indicator to inform a user of the apparatus when the flow of breathing gas rises above or falls below a predetermined level or range. Also described is a method of monitoring nitric oxide delivery, wherein the flow of breathing gas is measured and displayed. In some embodiments, an alert is provided when the flow of breathing gas rises above or falls below a predetermined level or range.
Drugs covered by this patent
- Inomax (NITRIC OXIDE) · Vero Biotech Inc
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-2148 |
— | Inomax |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.